Myocardial Infarction (MI)
64
27
31
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.6%
1 terminated out of 64 trials
91.7%
+5.1% vs benchmark
11%
7 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 11 completed trials
Clinical Trials (64)
Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease
Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke
The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial
Telegram Messenger Support for Smoking Cessation After Heart Attack
Eccentric Exercise Rehabilitation After Myocardial Infarction
Avatar-Based Serious Game for Cardiac Rehabilitation After Heart Attack
GSI Cardiac on Revolution Apex - US
Health Coaching for Patients With Cardiovascular Disease
Mannitol Administration for Delerium Prevention
Abbreviated Antithrombotic Therapy After PCI in Patients With AF and AMI
ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY
BEAT-SHOCK Registry
Can Wearable Technology be Used to Predict Exercise Intensity
The Impact of Audiovisual Structured Patient Education Material in Improving Clinical and Behavioural Outcomes in Home-Based Cardiac Rehabilitation Programme Participants
Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells
Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction
Prehospital Point-of-Care Hs-Troponin I for Rule-Out of Acute Myocardial Infarction in Patients Without ST-Segment Elevation
Clinical Echocardiography and S' Wave for Early Recognition of Acute Coronary Syndrome in the Emergency Department, A Prospective Study
Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF